CD56

A decreased level of CD56, a marker typically found on natural killer (NK) cells and a subset of T-lymphocytes, can signify various health issues and conditions. CD56+ cells are crucial for the immune system's ability to target and destroy infected or cancerous cells without prior sensitization. Below are some potential implications of decreased CD56 levels:

Implications of Decreased CD56 Levels

→ Immunodeficiency Disorders:
Conditions such as severe combined immunodeficiency (SCID) and other congenital immunodeficiencies can lead to low levels of CD56+ NK cells, resulting in increased susceptibility to infections.

→ Chronic Viral Infections:
Chronic infections, such as HIV, can deplete CD56+ NK cells. HIV specifically causes a progressive decline in various immune cell populations, including CD56+ cells.

→ Bone Marrow Suppression:
Diseases or treatments that suppress bone marrow function, such as chemotherapy, radiation therapy, or certain bone marrow disorders, can reduce the production of NK cells, including CD56+ cells.

→ Autoimmune Diseases:
Some autoimmune disorders may be associated with altered levels of NK cells. In these conditions, the immune system's regulation is disrupted, affecting CD56+ cell levels.

→ Stress and Chronic Illness:
Chronic stress and long-term illnesses can impact immune function, leading to changes in NK cell populations, including CD56+ cells.

→ Malnutrition and Nutritional Deficiencies:
Severe malnutrition or deficiencies in essential nutrients required for immune cell development can result in decreased levels of CD56+ cells.

→ Medications:
Certain medications, particularly immunosuppressants and corticosteroids, can decrease NK cell levels, including CD56+ cells.

→ Hematologic Malignancies:
Some blood cancers, such as leukemias and lymphomas, can affect NK cell populations and lead to decreased levels of CD56+ cells.

Clinical Implications

→ Increased Infection Risk:
Reduced CD56+ NK cell levels can impair the body’s ability to respond to infections, particularly viral infections.

→ Cancer Surveillance:
Lower levels of NK cells may diminish the body's natural ability to identify and eliminate cancerous cells, potentially increasing cancer risk.

→ Autoimmune and Chronic Conditions:
Monitoring CD56 levels can provide insights into the progression and management of autoimmune diseases and chronic conditions.

If a decreased level of CD56 is detected, it is important to investigate the underlying cause through a comprehensive clinical evaluation. Consulting with a healthcare provider can help interpret these findings in the context of other clinical information and guide appropriate diagnostic and therapeutic strategies.

CD56 is an adhesion molecule mediating homophilic and heterophilic adhesion in neurons, natural killer cells, and a small subset of CD4- and CD8-positive T cells. It is expressed in tumors with neuroendocrine differentiation (small cell lung carcinoma and neural-derived tumors) or natural killer cell lineage (subset of lymphomas). In normal small intestine, the ganglion cells in the muscle wall and nerves will show strong staining. Scattered lymphocytes may also be positive.